AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance (Q24648017)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42182973)
(Q373427)
(Q114442746)
(Q114442747)
(Q114442748)
(Q114442749)
(Q114428040)
(P304) 401-12
(P407) (Q1860)
(P433) 5
(P478) 16
(P577) Friday, November 6, 2009
(P921) (Q7141)
(Q729735)
(Q29496)
(P1433) (Q280018)
(P1476) "AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance" (language: en)
(P2093) Thomas O'Hare
William C Shakespeare
Xiaotian Zhu
Victor M Rivera
Frank Wang
Lauren T Adrian
Tianjun Zhou
Wei-Sheng Huang
Qihong Xu
Chester A Metcalf
Yaoyu Ning
Jeffrey A Keats
Yihan Wang
Raji Sundaramoorthi
Mathew Thomas
Dong Zhou
Joseph Snodgrass
Lois Commodore
Tomi K Sawyer
David C Dalgarno
Michael W N Deininger
(P2860) (Q24681743)
(Q27647525)
(Q28264038)
(Q28246193)
(Q28243392)
(Q29547900)
(Q29614280)
(Q30014844)
(Q34990280)
(Q37431597)
(Q39908034)
(Q37217153)
(Q36535476)
(Q33376325)
(Q35849776)
(Q40458599)
(Q33927591)
(Q34333693)
(Q42742043)
(Q46437032)
(Q46681622)
(Q46915157)
(Q46986026)
(Q45198729)
(Q80312874)
(Q80317123)
(Q81039035)
(Q26778468)
(Q29642803)
other details
aliases AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
description scientific article

External Links